Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.6M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
57.2K
-
Shares change
-
+32.5K
-
Total reported value, excl. options
-
$248K
-
Value change
-
+$141K
-
Number of buys
-
1
-
Price
-
$4.33
Significant Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2023
1 filings reported holding PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock as of Q4 2023.
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.2K shares
of 49.6M outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.8M shares), MILLENNIUM MANAGEMENT LLC (3.16M shares), Camber Capital Management LP (2.81M shares), ACADIAN ASSET MANAGEMENT LLC (1.92M shares), Athyrium Capital Management, LP (1.79M shares), Eversept Partners, LP (1.7M shares), RENAISSANCE TECHNOLOGIES LLC (1.67M shares), BlackRock Inc. (1.54M shares), GREAT POINT PARTNERS LLC (1.09M shares), and GLOBEFLEX CAPITAL L P (539K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.